127 related articles for article (PubMed ID: 9572893)
1. Conformationally defined retinoic acid analogues. 4. Potential new agents for acute promyelocytic and juvenile myelomonocytic leukemias.
Muccio DD; Brouillette WJ; Breitman TR; Taimi M; Emanuel PD; Zhang X; Chen G; Sani BP; Venepally P; Reddy L; Alam M; Simpson-Herren L; Hill DL
J Med Chem; 1998 May; 41(10):1679-87. PubMed ID: 9572893
[TBL] [Abstract][Full Text] [Related]
2. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
[TBL] [Abstract][Full Text] [Related]
3. Conformationally defined retinoic acid analogues. 5. Large-scale synthesis and mammary cancer chemopreventive activity for (2E,4E,6Z,8E)-8-(3',4'-dihydro-1'(2'H)-naphthalen-1'-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acid (9cUAB30).
Atigadda VR; Vines KK; Grubbs CJ; Hill DL; Beenken SL; Bland KI; Brouillette WJ; Muccio DD
J Med Chem; 2003 Aug; 46(17):3766-9. PubMed ID: 12904083
[TBL] [Abstract][Full Text] [Related]
4. Conformationally defined 6-s-trans-retinoic acid analogs. 2. Selective agonists for nuclear receptor binding and transcriptional activity.
Alam M; Zhestkov V; Sani BP; Venepally P; Levin AA; Kazmer S; Li E; Norris AW; Zhang XK; Lee MO
J Med Chem; 1995 Jun; 38(13):2302-10. PubMed ID: 7608895
[TBL] [Abstract][Full Text] [Related]
5. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
6. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
7. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells.
Duprez E; Lillehaug JR; Gaub MP; Lanotte M
Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of papilloma formation by analogues of 7,8-dihydroretinoic acid.
Shealy YF; Riordan JM; Frye JL; Simpson-Herren L; Sani BP; Hill DL
J Med Chem; 2003 May; 46(10):1931-9. PubMed ID: 12723955
[TBL] [Abstract][Full Text] [Related]
9. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
Duprez E; Lillehaug JR; Naoe T; Lanotte M
Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
[TBL] [Abstract][Full Text] [Related]
10. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment.
Park DJ; Chumakov AM; Vuong PT; Chih DY; Gombart AF; Miller WH; Koeffler HP
J Clin Invest; 1999 May; 103(10):1399-408. PubMed ID: 10330422
[TBL] [Abstract][Full Text] [Related]
11. Design and stereoselective synthesis of retinoids with ferrocene or N-butylcarbazole pharmacophores that induce post-differentiation apoptosis in acute promyelocytic leukemia cells.
Ivanova D; Gronemeyer H; de Lera AR
ChemMedChem; 2011 Aug; 6(8):1518-29. PubMed ID: 21506276
[TBL] [Abstract][Full Text] [Related]
12. Andrographolide inhibits growth of acute promyelocytic leukaemia cells by inducing retinoic acid receptor-independent cell differentiation and apoptosis.
Manikam SD; Stanslas J
J Pharm Pharmacol; 2009 Jan; 61(1):69-78. PubMed ID: 19126299
[TBL] [Abstract][Full Text] [Related]
13. Retinoid target genes in acute promyelocytic leukemia.
Pitha-Rowe I; Petty WJ; Kitareewan S; Dmitrovsky E
Leukemia; 2003 Sep; 17(9):1723-30. PubMed ID: 12970771
[TBL] [Abstract][Full Text] [Related]
14. The endogenous retinoid metabolite S-4-oxo-9-cis-13,14-dihydro-retinoic acid activates retinoic acid receptor signalling both in vitro and in vivo.
Schuchardt JP; Wahlström D; Rüegg J; Giese N; Stefan M; Hopf H; Pongratz I; Håkansson H; Eichele G; Pettersson K; Nau H
FEBS J; 2009 Jun; 276(11):3043-59. PubMed ID: 19490107
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant effects of synthetic retinoids and activated vitamin D3.
Koyama T; Hirosawa S
Semin Thromb Hemost; 1998; 24(3):217-26. PubMed ID: 9701451
[TBL] [Abstract][Full Text] [Related]
16. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
17. Cooperative action of 1alpha,25-dihydroxyvitamin D3 and retinoic acid in NB4 acute promyelocytic leukemia cell differentiation is transcriptionally controlled.
Bastie JN; Balitrand N; Guillemot I; Chomienne C; Delva L
Exp Cell Res; 2005 Nov; 310(2):319-30. PubMed ID: 16181625
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid receptors: from molecular mechanisms to cancer therapy.
di Masi A; Leboffe L; De Marinis E; Pagano F; Cicconi L; Rochette-Egly C; Lo-Coco F; Ascenzi P; Nervi C
Mol Aspects Med; 2015 Feb; 41():1-115. PubMed ID: 25543955
[TBL] [Abstract][Full Text] [Related]
19. Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid.
Jiang W; Deng W; Bailey SK; Nail CD; Frost AR; Brouillette WJ; Muccio DD; Grubbs CJ; Ruppert JM; Lobo-Ruppert SM
Cancer Biol Ther; 2009 Feb; 8(3):289-98. PubMed ID: 19197145
[TBL] [Abstract][Full Text] [Related]
20. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
